These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6619033)

  • 41. [Comparative antibacterial effect of azlocillin, ticarcillin and carbenicillin on pseudomonas bacteria].
    Jotzoff M
    Med Welt; 1981 Sep; 32(39):1448-9. PubMed ID: 7300647
    [No Abstract]   [Full Text] [Related]  

  • 42. A perspective on new beta-lactam antibiotics in pediatric patients.
    Nelson JD
    Bull N Y Acad Med; 1984 May; 60(4):374-9. PubMed ID: 6372913
    [No Abstract]   [Full Text] [Related]  

  • 43. [Factors, affecting penicillin therapy].
    Knudsen ET
    Antibiotiki; 1971 Jun; 16(6):525-9. PubMed ID: 5112487
    [No Abstract]   [Full Text] [Related]  

  • 44. Successful treatment of multiresistant pseudomonas peritonitis with combination of azlocillin and amikacin.
    Leung AC; Gribben J; Sleigh JD; Boulton Jones JM
    Scott Med J; 1983 Jan; 28(1):69-70. PubMed ID: 6403983
    [No Abstract]   [Full Text] [Related]  

  • 45. Fosfomycin, piperacillin, azlocillin. Correlation between therapeutic response of mice infected with Pseudomonas aeruginosa and in vitro data.
    Haag R
    Chemotherapy; 1984; 30(4):227-36. PubMed ID: 6430654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
    Canton P
    Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Perichondritis of the auricula. Prevention of defective healing with azlocillin].
    Ganz H
    HNO; 1982 Nov; 30(11):428-9. PubMed ID: 7161155
    [No Abstract]   [Full Text] [Related]  

  • 48. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
    Grenier B; Gilly R
    Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Azlocillin and mezlocillin. New penicillins and their value].
    Graber H; Arr M; Csiba A; Ludwig E; Magyar T
    Orv Hetil; 1981 Mar; 122(13):749-56. PubMed ID: 6457268
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
    Johnson M; Miniter P; Andriole VT
    J Infect Dis; 1987 Apr; 155(4):783-8. PubMed ID: 3102631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An update on the efficacy of ciprofloxacin in animal models of infection.
    Andriole VT
    Am J Med; 1989 Nov; 87(5A):32S-34S. PubMed ID: 2589379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Balance of clinical evaluations].
    MMW Munch Med Wochenschr; 1980 Feb; 122(5):42, 45. PubMed ID: 6445038
    [No Abstract]   [Full Text] [Related]  

  • 54. International clinical experience with azlocillin.
    Schacht P; Arcieri G; Bruck H; Griffith E; Hullman R; Tettenborn D
    J Antimicrob Chemother; 1983 May; 11 Suppl B():215-22. PubMed ID: 6619030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serious infections caused by diphtheroids.
    Johnson WD; Kaye D
    Ann N Y Acad Sci; 1970 Oct; 174(2):568-76. PubMed ID: 5278136
    [No Abstract]   [Full Text] [Related]  

  • 56. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
    Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged bleeding time during azlocillin therapy.
    Dijkmans BA; Van Der Meer JW; Boekhout-Mussert MJ; Zaal-De Jong M; Mattie H
    J Antimicrob Chemother; 1980 Jul; 6(4):554-6. PubMed ID: 7430018
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical experiments with a new derivative of 6-aminopenicillanic acid: hetacillin potassium].
    Soranzo ML; Bosio G
    Minerva Med; 1972 Nov; 63(82):4453-8. PubMed ID: 4565935
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy and safety of azlocillin and ticarcillin in febrile neutropenic children with cancer: a comparative study.
    Kosmidis H; Varvoutsi M; Kafetzis D; Koupari G; Bouhoutsou D; Papadatos C
    Chemioterapia; 1987 Jun; 6(2 Suppl):396-8. PubMed ID: 3334581
    [No Abstract]   [Full Text] [Related]  

  • 60. [Role of azlocillin in the treatment of Pseudomonas aeruginosa otitis in children].
    Damay M; Ployet MJ; Borderon JC
    Presse Med; 1984 Mar; 13(13):812-4. PubMed ID: 6231601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.